TY - STD TI - International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6(R1). 1996, [http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf] UR - http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf ID - ref1 ER - TY - JOUR AU - Baigent, C. AU - Harrell, F. E. AU - Buyse, M. AU - Emberson, J. R. AU - Altman, D. G. PY - 2008 DA - 2008// TI - Ensuring trial validity by data quality assurance and diversification of monitoring methods JO - Clin Trials VL - 5 UR - https://doi.org/10.1177/1740774507087554 DO - 10.1177/1740774507087554 ID - Baigent2008 ER - TY - STD TI - Effective and Efficient Monitoring as a Component of Quality. [http://ctti-clinicaltrials.org/what-we-do/study-conduct/monitoring] UR - http://ctti-clinicaltrials.org/what-we-do/study-conduct/monitoring ID - ref3 ER - TY - STD TI - MRC/DH/MHRA Joint Project. Risk-adapted Approaches to the Management of Clinical Trials of Investigational Medicinal Products. 2011,http://www.mhra.gov.uk/home/groups/l-ctu/documents/websiteresources/con111784.pdf, UR - http://www.mhra.gov.uk/home/groups/l-ctu/documents/websiteresources/con111784.pdf ID - ref4 ER - TY - STD TI - Food and Drug Administration. Guidance for Industry Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring. 2013, [http://www.fda.gov/downloads/Drugs/…/Guidances/UCM269919.pdf Accessed 19/12/2013] UR - http://www.fda.gov/downloads/Drugs/.../Guidances/UCM269919.pdf ID - ref5 ER - TY - STD TI - European Medicines Agency: Reflection paper on risk based quality management in clinical trials. 2013, [http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/11/WC500155491.pdf] UR - http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/11/WC500155491.pdf ID - ref6 ER - TY - JOUR AU - Morrison, B. W. AU - Cochran, C. J. AU - White, J. G. AU - Harley, J. AU - Kleppinger, C. F. AU - Liu, A. AU - Mitchel, J. T. AU - Nickerson, D. F. AU - Zacharias, C. R. AU - Kramer, J. M. AU - Neaton, J. D. PY - 2011 DA - 2011// TI - Monitoring the quality of conduct of clinical trials: a survey of current practices JO - Clin Trials VL - 8 UR - https://doi.org/10.1177/1740774511402703 DO - 10.1177/1740774511402703 ID - Morrison2011 ER - TY - JOUR AU - Tudur Smith, C. AU - Stocken, D. AU - Dunn, J. AU - Cox, T. AU - Ghaneh, P. AU - Cunningham, D. AU - Neoptolemos, J. P. PY - 2012 DA - 2012// TI - The value of source data verification in a cancer clinical trial JO - Plos One VL - 7 UR - https://doi.org/10.1371/journal.pone.0051623 DO - 10.1371/journal.pone.0051623 ID - Tudur Smith2012 ER - TY - JOUR AU - Bakobaki, J. M. AU - Rauchenberger, M. AU - Joffe, N. AU - McCormack, S. AU - Stenning, S. AU - Meredith, S. PY - 2012 DA - 2012// TI - The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial JO - Clin Trials VL - 9 UR - https://doi.org/10.1177/1740774511427325 DO - 10.1177/1740774511427325 ID - Bakobaki2012 ER - TY - STD TI - Prospective cluster-randomized investigation into strategies adapted on a study-specific basis for on-site monitoring in conjunction with additional quality assurance measures. [http://www.adamon.de/ADAMON_EN/Home.aspx] UR - http://www.adamon.de/ADAMON_EN/Home.aspx ID - ref10 ER - TY - JOUR AU - Journot, V. AU - Pignon, J. P. AU - Gaultier, C. AU - Daurat, V. AU - Bouxin-Metro, A. AU - Giraudeau, B. AU - Preux, P. M. AU - Treluyer, J. M. AU - Chevret, S. AU - Plattner, V. AU - Thalamas, C. AU - Clisant, S. AU - Ravaud, P. AU - Chene, G. PY - 2011 DA - 2011// TI - Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study JO - Contemp Clin Trials VL - 32 UR - https://doi.org/10.1016/j.cct.2010.10.001 DO - 10.1016/j.cct.2010.10.001 ID - Journot2011 ER - TY - JOUR AU - Buyse, M. G. S. AU - Evans, S. AU - Geller, N. L. AU - Ranstam, J. AU - Scherrer, B. AU - Lesaffre, E. AU - Murray, G. AU - Edler, L. AU - Hutton, J. AU - Colton, T. AU - Lachenbruch, P. AU - Verma, B. L. PY - 1999 DA - 1999// TI - The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials JO - Stat Med VL - 18 UR - https://doi.org/3.0.CO;2-O DO - 3.0.CO;2-O ID - Buyse1999 ER - TY - BOOK PY - 2012 DA - 2012// TI - Work stream 6: Pharmacovigilance ID - ref13 ER - TY - JOUR AU - Gamble, C. AU - Wolf, A. AU - Sinha, I. AU - Spowart, C. AU - Williamson, P. R. PY - 2013 DA - 2013// TI - The role of systematic reviews in pharmacovigilance planning and clinical trials authorisation application: example from the SLEEPS trial JO - Plos One VL - 8 UR - https://doi.org/10.1371/journal.pone.0051787 DO - 10.1371/journal.pone.0051787 ID - Gamble2013 ER -